Interestingly, investigation into the temporal dynamics of identified autoanti-bodies revealed a proportion of antibodies that were likely present pre-infection (including those against IFNα2 and IL1β), illustrating the complex nature of whether pre-existing autoantibodies increase susceptibility to infection and progression of COVID-19 or whether they result from the infection itself. The gene discussed is IL1B; the disease is COVID-19.